Determination of the Minimal Detectable Change of the Parkinson's Disease Questionnaire-8
Determination of the Minimal Detectable Change and Minimum Clinically Important Change Score of the Parkinson's Disease Questionnaire-8
Emre Şenocak
39 participants
May 13, 2024
OBSERVATIONAL
Conditions
Summary
This study is conducted to determine how many units of improvement the Parkinson's Disease Questionnaire-8 (PDQ-8), used to evaluate the quality of life of Parkinson's patients, should have to express a significant change in the quality of life. Patients for whom a 30-session physiotherapy program is recommended will be included in the study. Patients will be asked to express the change in their quality of life at the end of treatment. The PDQ-8 survey and Global Rating of Patient-Perceived Changes (GRP-PC) forms will be used to determine these changes. Evaluations will be repeated at the beginning of the treatment program and at the end of the 30th session.
Eligibility
Inclusion Criteria3
- Having regular neurology follow-up and using medicine;
- Hoehn and Yahr Scale Stage between 1-3 points;
- Mini-Mental State Assessment Score \>24 points;
Exclusion Criteria7
- Having a secondary neurological disease;
- Any surgery and/or trauma affecting the upper extremity
- Having complaints of pain before the treatment program;
- There was a change in medical treatment during the study;
- With symptoms of anxiety and depression;
- Those who use alcohol and drugs;
- Individuals with vision defects that cannot be corrected by the use of glasses and those with hearing loss
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
A routine physical therapy program prescribed by a specialist physician and physiotherapist will be applied.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06487364